Acucela, Otsuka Enter Deals For Eye Drugs
This article was originally published in PharmAsia News
Executive Summary
Acucela's deal with Otsuka to develop two eye-disorder drugs follows news of the plan by Shionogi to buy out Sciele, pointing up the continued interest from Japanese pharma in U.S. firms